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ess: R.J.H.Koppers@znbSummary Normocapnic hyperpnea has been established as a method of respiratory
muscle endurance training (RMET). This technique has not been applied on a large scale
because complicated and expensive equipment is needed to maintain CO2-homeostasis
during hyperpnea. This CO2-homeostasis can be preserved during hyperpnea by
enlarging the dead space of the ventilatory system. One of the possibilities to enlarge
dead space is breathing through a tube. If tube breathing is safe and feasible, it may be
a new and inexpensive method for RMET, enabling its widespread use.
The aim of this study was to evaluate the safety of tube breathing and investigate
the effect on CO2-homeostasis in healthy subjects.
A total of 20 healthy volunteers performed 10min of tube breathing (dead space 60%
of vital capacity). Oxygen-saturation, PaCO2, respiratory muscle function, hypercapnic
ventilatory response and dyspnea (Borg-score) were measured. Tube breathing did not
lead to severe complaints, adverse events or oxygen desaturations. A total of 14 out of
20 subjects became hypercapnic (PaCO246.0 kPa) during tube breathing. There were no
significant correlations between PaCO2 and respiratory muscle function or hypercapnic
ventilatory responses. The normocapnic versus hypercapnic subjects showed no
significant differences between decrease in oxygen saturation (–0.7% versus –0.2%,
respectively, P ¼ 0:6), Borg score (4.3 versus 4.7, P ¼ 0:9), respiratory muscle function
nor hypercapnic ventilatory responses.
Our results show that tube breathing is well tolerated amongst healthy subjects. No
complaints, nor desaturations occurred. Hypercapnia developed in a substantial number
of subjects. When tube breathing will be applied as respiratory muscle training
modality, this potential development of hypercapnia must be considered.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
866190; fax: +31 582866122.
.nl (R.J.H. Koppers).
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The function of respiratory muscles can improve in
response to training. Normocapnic hyperpnea is
probably the best technique for improving endur-
ance respiratory muscle function, which is required
during exercise.1 During normocapnic hyperpnea
the subject has to sustain a period of hyperpnea for
about 10–15min. Respiratory Muscle Endurance
Training (RMET) is based on the principle of
normocapnic hyperpnea. RMET, performed with a
specially designed, expensive electromechanical
device showed an improvement of 268% in breath-
ing endurance in healthy sedentary subjects, and
moreover, the endurance time of a sub-maximal
exercise test increased with 50% in this study
without placebo-training group.2 RMET also led to
improvements in respiratory muscle function and
exercise performance in a study in trained athletes,
also without a placebo group and in a randomized
controlled trial in patients with Chronic Obstructive
Pulmonary Disease (COPD).3,4
Despite these promising results, RMET is not
applied on a large scale because of this compli-
cated and expensive equipment that is needed to
maintain O2 and CO2-homeostasis during hyperp-
nea. This CO2-homeostasis can also be preserved
during a period of hyperpnea by enlarging the dead
space of the ventilatory system. One of the
possibilities to do so is to breathe through a tube.
Thus, RMET by means of tube breathing might be a
new, inexpensive method to perform respiratory
muscle training, possibly even in a home-based
setting. However, the safety and the effects of this
kind of tube breathing on CO2-homeostasis have
never been evaluated.
Therefore, we investigated whether tube breath-
ing might be a safe and inexpensive technique to
perform RMET, enabling widespread use.
The aim of this study was to study the safety and
feasibility of tube breathing in healthy subjects. We
therefore evaluated oxygenation, perception of
dyspnea and CO2-homeostasis in 20 healthy volun-
teers during tube breathing.Subjects and methods
The study population consisted of 20 healthy
subjects (13 females) (Table 1). Exclusion criteria
were: a pulmonary medical history, pulmonary
complaints and current smoking. Subjects were
recruited by means of an advertisement in a free
local paper. The subjects were informed about the
purpose of this study and gave informed consent.The study was approved by the Ethics Committee of
the University Hospital Nijmegen.
Pulmonary function test
Pulmonary function tests at rest were measured
according to ERS-criteria5 with a Sensorloop spi-
rometer (Sensormedics corporation, Bilthoven, the
Netherlands): forced vital capacity (FVC) and
forced expiratory volume in 1 s (FEV1) were
recorded.
Hypercapnic ventilatory response
The steady-state ventilatory response to CO2 was
measured. Subjects breathed in a closed spirom-
eter circuit (Godart, Bilthoven, the Netherlands) in
which the soda lime absorber could be partially
bypassed with a three-way valve. Oxygen was
supplemented. End-tidal PCO2 was monitored at
the mouth (Drager, Type 8290000). After at least
5min, when the end-tidal PCO2 value was stabi-
lized, the soda-lime absorber was partially by-
passed. When the end-tidal PCO2 increased by 1 kPa
the bypass around the soda-lime absorber was
readjusted to prevent the end-tidal PCO2 from
rising any further. After 5min in this steady state,
the test was ended. Tidal volume and breathing
frequency were obtained from the spirometer and
were converted to minute volume of ventilation
(VE). The ventilatory response (S) to carbon dioxide
is the slope of the relationship of ventilation versus
end-tidal PCO2 (l/min/kPa).
6,7
PImax/PEmax
Maximal static inspiratory and expiratory mouth
pressures (PImax and PEmax) were measured using a
flanged mouthpiece connected to a rigid, plastic
tube with a small air leak. Pressure was measured
with a pressure transducer (Validyne, Northridge,
CA, USA) and recorded (Kipp and Zonen, Delft, the
Netherlands). Plateau levels for PImax were mea-
sured from residual volume, for PEmax from total
lung capacity.8
Threshold loading
Inspiratory threshold loading was used to measure
inspiratory muscle endurance.
Subjects, wearing a nose clip, were connected
with a mouthpiece to a threshold loading device.9
They inspired against a loaded valve, starting with
a load equal to 10% of PImax, and 25 g weights
were added at 1.5min intervals.10 Pressure was
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Table 1 Variables for normocapnic versus hypercapnic group.
Variable Normocapnic
mean (SD)
Hypercapnic
mean (SD)
P-value (between groups)
Female/male 4/2 9/5
Age (yr) 21 (2) 29 (13) 0.9
Height (cm) 176 (15) 177 (11) 0.7
Weight (kg) 73 (13) 74 (12) 0.3
FEV1 (l) 4.0 (1.1) 3.9 (0.6) 0.9
FEV1 (% predicted) 100 (12) 103 (10) 0.9
FVC (l) 4.6 (1.4) 4.4 (0.6) 0.7
FVC (%predicted) 97 (10) 97 (14) 0.9
PaCO2 rest (kPa) 5.1 (0.3) (38mmHg) 5.3 (0.4) (40mmHg) 0.9
TBPaCO2 (kPa) 5.2 (0.7) (39mmHg) 6.6 (0.4) (50mmHg) 0.01
Delta PaCO2 (tube-rest (kPa)) 0.09 (0.60) (1mmHg) 1.29 (0.50) (10mmHg) 0.01
SaO2 rest 98.5 (0.5) 96.2 (2.0) 0.02
SaO2 tube 97.8 (2.0) 95.9 (1.0) 0.02
Delta SaO2 (tube-rest (%)) 0.7 (1.9) 0.2 (1.9) 0.6
Heart beats/min rest 74 (6) 70 (11) 0.5
Heart beats/min tube 81 (10) 81 (12) 0.7
Borg 4.3 (2.9) 4.7 (1.9) 0.9
S (l/min/kPa) 6.7 (4.7) 10.8 (7.2) 0.7
SIPmax (kPa) 3.6 (1.6) 4.5 (1.9) 0.2
PImax (kPa) 7.1 (2.7) 8.7 (2.4) 0.2
PImax (% pred) 82 (32) 99 (28) 0.3
PEmax (kPa) 9.8 (3.9) 10.1 (3.1) 0.7
PEmax (% pred) 86.5 (29.1) 88.1 (26.3) 1.0
Data reported as mean (standard deviation).
FEV1, forced expiratory volume in liters in 1 s; FVC, forced vital capacity in liters; PaCO2, capillary blood pressure of carbon
dioxide; PaCO2 rest, PaCO2 at rest/before tube breathing; TBPaCO2, PaCO2 at the end of 10minutes tube breathing; Delta PaCO2
tube-rest, difference between PaCO2 value during tube breathing and resting value; SaO2 rest, oxygen saturation at rest; SaO2
tube, oxygen saturation at the end of 10min tube breathing; Delta SaO2 tube-rest, difference between SaO2 value during tube
breathing and resting value; Borg, Borg-score at the end of tube breathing; S, slope of ventilatory response to CO2; SIPmax,
maximal sustainable inspiratory pressure in kilopascal; PImax, maximal inspiratory pressure in kilopascal; PImax % pred, maximal
inspiratory pressure as percentage from reference value; PEmax, maximal expiratory pressure in kilopascal; PEmax % pred,
maximal expiratory pressure as percentage from reference value.
R.J.H. Koppers et al.716measured inside the mouthpiece with a pressure
transducer (Validyne, Northridge, CA, USA).
Breathing was continued until inspiration could no
longer be sustained. The pressure achieved during
the heaviest load tolerated for at least 45 s was
defined as the maximal sustainable inspiratory
pressure (SIPmax).External dead space ventilation (tube
breathing)
The external dead space consisted of a wide-bore
spirometer-tube (internal diameter 3 cm, prelimin-
ary measured resistance of 1m of tube: 0.03 kPa/l/
s), connected to a mouthpiece. The length of the
tube, representing the dead space, was adjusted to
60% of the FVC,2 because during exercise, when
minute ventilation rises, tidal volume increases toabout 60% of the vital capacity and remains
constant thereafter.11 A capnograph (Drager, Type
8290000) was connected to the mouthpiece, to
monitor the end-tidal PCO2. The sampled gas was
returned from the capnograph to the mouthpiece.
The subjects breathed through the tube during
10min, at an imposed frequency of 15 breaths/min,
and at an inspiratory versus expiratory-time ratio of
1:2, using a metronome (Qwik Time QT5, quartz
metronome). Before the experiment subjects were
instructed to take deep breaths, to overcome the
large dead space. They were seated and rested
during 3min. At 30 s before the start of tube
breathing (PaCO2 rest) and 30 s before ending tube
breathing (TBPaCO2), an arterialized capillary
blood-gas sample was taken from a warmed
fingertip. Arterial oxygen saturation and heart rate
were measured noninvasively by oximetry (Nonin
Medical Inc., USA Model 8500 MA). Perception of
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with a modified Borg-scale (BORG).12Protocol
After the pulmonary function test, the hypercapnic
ventilatory response was determined, followed by
measurement of PImax and PEmax. Next threshold
loading was performed. The 3 h session ended with
tube breathing. All experiments were performed in
the late morning and early afternoon.
Subjects rested for 20min between each test.Statistics
Pearson correlations between different parameters
were determined. Furthermore, subjects were
divided into two groups: normocapnic versus
hypercapnic, which was dependent on their TBPa-
CO2. A PaCO2p6.0 kPa was defined as normocapnia.
Mean values between groups were compared. Data
are reported as mean7SD. The Mann–Whitney U-
test was used to test significant differences
between the two groups. Significance was set at
Po0:05. Statistics were performed using SPSS.Results
Table 1 shows the characteristics and the results of
the subjects.
Tube volumes ranged from 2.0 to 4.4 l ( ¼ 60% of
FVC). During tube breathing, 14 out of 20 subjects
became hypercapnic (TBPaCO246 kPa). Besides of
dyspnea, there were neither severe complaints, nor
adverse events. There were no significant correla-
tions between PaCO2 and the ventilatory response
to CO2, PImax, PEmax or SIPmax. Subsequently, the
subjects were divided into two groups to compare
mean values: normocapnic versus hypercapnic at
the end of tube breathing. In the normocapnic
group, PaCO2 remained constant: 5.1 (0.3) kPa
[mean (7SD)] at rest, versus 5.2 (0.7) kPa at the
end of 10min tube breathing (range during tube
breathing 4.2–6.0 kPa). In the hypercapnic group,
PaCO2 showed a rise from 5.3 (0.4) kPa at rest, to
6.6 (0.4) kPa, P ¼ 0:001 (range during tube breath-
ing 6.1–7.7 kPa). A significant difference was found
for oxygen saturation at rest as well as at the end of
tube breathing, P ¼ 0:02 (Table 1). However, the
change in oxygen saturation (tube breathing value
minus resting value) did not differ significantly
between the groups: normocapnic group –0.7%versus hypercapnic group 0.2%, P ¼ 0:6. Clinically
relevant desaturations did not occur in neither
group. Lowest saturation in both groups was 94%.
No significant differences in heart rate at rest,
heart rate during tube breathing, or perception of
dyspnea (BORG) were recorded among the normo-
capnic and hypercapnic groups. Subjects had no
complaints during tube breathing, besides of
dyspnea.
Normocapnic and hypercapnic subjects showed
no significant differences in the following charac-
teristics: age, height, weight, FEV1, FVC, PaCO2
rest.
The ventilatory response to CO2 (S) was not
significantly different for the normocapnic (6.7 l/
min/kPa (4.7)) versus the hypercapnic group
(10.8 l/min/kPa (7.2)), P ¼ 0:2.
The normocapnic and hypercapnic subjects did
not differ significantly in maximal inspiratory
pressure (PImax) and maximal expiratory pressure
(PEmax). PImax was within a normal range in both
groups: normocapnic: 82% (32%) predicted, versus
hypercapnic 99% (28%) predicted, P ¼ 0:3.8
Inspiratory muscle endurance measured with
incremental threshold loading, showed no signifi-
cant differences between the normocapnic and
hypercapnic subjects: SIPmax 3.6 (1.6) kPa versus
4.5 (1.9) kPa, respectively, P ¼ 0:2.Discussion
The present study shows that tube breathing in
healthy volunteers is well tolerated. No clinically
significant desaturations, severe complaints or
adverse events occurred. It leads to hypercapnia
in several subjects. Thus tube breathing might be a
feasible and inexpensive method to perform RMET,
which suggests that it could become available to a
large population. However, the potential develop-
ment of hypercapnia must be considered when tube
breathing will be applied as endurance training for
the respiratory muscles.
To our knowledge this is the first study, evaluat-
ing tube breathing as a new method for RMET.
Therefore, we investigated the safety of this
method, first of all in healthy subjects. Tube
breathing in our study did not lead to severe
complaints, adverse events or relevant oxygen
desaturations. A heart rate of 81 beats/min at the
end of 10min tube breathing does not reflect
severe stress. Perception of dyspnea (Borg-score)
was moderate to severe at the end of the tube
breathing session.
We also looked at the effects of tube breathing
on CO2-homeostasis. Strikingly, ventilation was not
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breathing in all healthy subjects and consequently
alveolar hypoventilation occurred. One of the
limitations of this study is the fact that we did
not measure tidal volumes and minute ventilation
during tube breathing in our subjects. Thus, the
question remains whether tidal volumes or prob-
ably the fixed respiratory rate (15 breaths/min), or
a combination of these two variables, were the
limiting factors in achieving an adequate alveolar
ventilation. On the other hand, the net effect of
the alveolar ventilation was measured on end-tidal
PCO2. This partly obviates the necessity to measure
minute ventilation as such. However, as a conse-
quence, hypercapnia developed in this subset of
subjects. Brief increases in PaCO2 (lasting several
minutes) produce a sensation of respiratory dis-
comfort (air hunger), which is neither a harmful,
nor a dangerous situation. Hypercapnia also leads
to cerebral vasodilatation and it diminishes in- and
expiratory upper airway resistance.13,14 In several
studies (in healthy subjects), the effect of induced
acute hypercapnia on ventilation was evalu-
ated.15–17 However, the design of these studies
was different from ours because, spontaneous
breathing was compared tomechanical ventilation.
It was shown that ventilation at the same level of
hypercapnia, increased even more during sponta-
neous breathing, compared to mechanical ventila-
tion. Furthermore, air hunger was much lower at
the same level of hypercapnia during spontaneous
breathing compared to mechanical ventilation.
Mean levels of PaCO2 ranged from 6.1 to 6.9 kPa.
Thus, it can be speculated that a small rise in PaCO2
during tube breathing might even lead to a more
intense training stimulus. Moreover, even pro-
longed exposure (5 days) to elevated levels of CO2
in healthy subjects, did not alter the ventilatory
chemosensitivity to subsequent acute hypercap-
nia.18
However, chronic hypercapnia due to respiratory
muscle failure is an important complication and a
poor prognostic marker, especially in patients with
COPD.19 On the other hand, especially these
patients are eligible for respiratory muscle training
to attempt to prevent or postpone this respiratory
muscle failure, which is, among other things,
caused by impaired respiratory muscle function.20
Nevertheless, before applying RMET by means of
tube breathing to patients with COPD, the safety,
applicability and the appropriate training scheme
of this technique have to be investigated in these
patients.
In Jederlinic’s classical study on resistance
stress-testing and training of respiratory muscles
in COPD-patients, these authors found that allpatients hypoventilated, and desaturated.21 How-
ever, some of their patients were already hypoxe-
mic at the start of the test (SaO2, 84%). When
performing this resistive stress test, Jederlinic’s
patients hypoventilated. The ‘‘wisdom of their
bodies’’ had to make a choice between very strong
exertion of their respiratory muscles versus accept-
ing some degree of hypercapnia. Apparently, they
chose the latter. The subjects in our study, and also
possibly future patients, face similar choices. As
the resistive load in our study was distinctly lower
than in Jederlinic’s study, one might expect that
the urge/need to trade off a heavy respiratory load
for some degree of hypercapnia, might be less.
Dead space breathing or tube breathing has been
studied in the past; however, these studies are not
comparable to our study design because our
subjects were instructed to take deep breaths to
overcome the large dead space (RMET modality),
whereas in the other tube breathing studies the
investigators looked at the spontaneous (physiolo-
gical) effects of tube breathing on ventilation.22–25
In determining the safety of tube breathing, we
looked, among other things, at oxygen saturation.
The upper part of the oxygen saturation curve
levels off, which means that the partial pressure of
O2 might fall while the oxygen saturation is still
normal. However, the lowest saturation measured
was 94%, which is not associated with (relevant)
hypoxemia. This observation, along with dyspnea
scores and heart rate during tube breathing,
underlines that tube breathing is a safe method.
The striking observation that hypercapnia devel-
oped in a large number of subjects could be
explained by several mechanisms, which will be
discussed below.
A difference in the sensitivity of the chemor-
eceptors to a certain change in PaCO2 might be
responsible for the development of hypercapnia
during tube breathing. This response to CO2 is
mediated centrally by brainstem chemoreceptors
in the medulla and peripherally by the carotid and
aortic bodies. A wide range of ventilatory responses
to CO2 has been reported in the literature.
26 Our
subjects also showed a wide variance and the
results of the hypercapnic ventilatory response
could not explain the difference in TBPaCO2
between the two groups.
Inspiratory muscle fatigue may lead to acute
hypercapnic respiratory failure. One study investi-
gated the effect of diaphragmatic fatigue on
control of respiratory muscles and ventilation
during CO2 rebreathing in healthy volunteers. It
was concluded that diaphragmatic fatigue induces
proportionally greater contributions of inspiratory
rib cage muscles, resulting in the preservation of
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diaphragmatic contractility.27 Diaphragmatic fati-
gue measured by cervical magnetic stimulation
occurs following voluntary hyperpnea (until task
failure), and lasts for at least 1 h after hyperpnea.28
The subjects in this study breathed at 60% MVV
during 517758 s with a respiratory rate of
8975 breaths/min. Our subjects were healthy
volunteers, breathing with a respiratory rate of
15 breaths/min. Furthermore PImax was within a
normal range in both groups. Therefore, respiratory
muscle fatigue or weakness cannot explain the
difference in TBPaCO2 between both groups.
There was a wider range of ages and there were
more females in the hypercapnic group. It is
difficult to establish whether this might have
played a role in becoming hypercapnic. Despite
this, they were all healthy subjects of whom it is
difficult to estimate retrospectively whether these
factors may have played a role in becoming
hypercapnic. This would require another study.
Furthermore, the sample size in our study could
have contributed to the absence of statistically
significant differences between the different para-
meters.
Based on the knowledge that tube breathing
leads to a stimulation of ventilation because it
increases the amplitude and leads to a change in
the timing of the respiratory oscillations in arterial
PCO2, we would have expected our subjects to
remain at least normocapnic, and possibly some-
what hypocapnic.23–25 However, several subjects
became hypercapnic. Neither respiratory muscle
endurance, nor chemoreceptor sensitivity was
significantly different between the groups,
although the wide range in ventilatory responses
to CO2 makes it hard to detect significant differ-
ences. Especially when taken into account the
small number of subjects that were studied, and
therefore a type-II error cannot be excluded.
Despite these statistical remarks, these subjects
‘‘accepted’’ a higher PaCO2 value, rather than
increase their minute ventilation and thus their
work of breathing, in spite of the fact that there
still was a breathing reserve. The perception of the
work of breathing at the end of tube breathing was
the same in both groups as shown by the Borg
scores. Similar differences can be observed in
patients with severe COPD. Some maintain a high
ventilation in order to remain normocapnic (so
called ‘‘pink puffers’’), and others do not seem to
be bothered by the hypercapnia (so called ‘‘blue
bloaters’’). This fits with the recently proposed
theory of natural wisdom, that protects these
patients from the detrimental consequences of
their disease, but with the inevitable cost ofhypercapnia.29 It is, of course, extremely spec-
ulative to suggest that possibly these types of
reactions may already be present in early life,
before COPD ever develops. However, it is a known
fact that there are great interindividual differences
in ventilatory sensitivity to CO2 and there are
several reports suggesting that heredity plays a
very important role.25 Thus genetic set differences
might determine the tendency to normocapnia or
hypercapnia during tube breathing.
The observation that tube breathing is well
tolerated in healthy subjects, might have impor-
tant implications for the applicability of this
training technique. Nevertheless, further studies
are necessary before application of RMET by means
of tube breathing can be recommended as safe in
healthy subjects and these findings need to be
confirmed in patients with COPD. The equipment
for tube breathing is inexpensive and almost
everywhere available. This means that RMET by
means of tube breathing can be applied on a larger
scale: in clinical research, and eventually in routine
clinical use.
In summary, the results of this experiment show
that tube breathing is well tolerated in healthy
subjects. It does not lead to complaints, adverse
events or desaturations. It results in hypercapnia in
a substantial number of subjects. This response
could not be related to any characteristics of the
subjects. When tube breathing will be applied as a
respiratory muscle training modality, this potential
development of hypercapnia must be considered.
Furthermore, the appropriate training scheme in
healthy subjects and the safety and applicability of
tube breathing in patients with COPD needs further
investigations.Acknowledgement
Grant: Netherlands Asthma Foundation project no.
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